REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210429:nBw4NCLVla&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 28 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,747,313 1.35% 175,858 0.14%
(2) Derivatives (other than options):
72,359 0.06% 7,134 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,825,772 1.42% 189,092 0.15%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 236.2300 USD
Purchase 1 245.6050 USD
Purchase 3 245.2900 USD
Purchase 21 245.1800 USD
Purchase 83 240.0000 USD
Purchase 100 244.9700 USD
Purchase 100 240.6950 USD
Purchase 100 240.1450 USD
Purchase 200 235.2800 USD
Purchase 200 240.2625 USD
Purchase 200 240.0675 USD
Purchase 202 239.7366 USD
Purchase 236 245.8806 USD
Purchase 300 239.7683 USD
Purchase 300 243.8133 USD
Purchase 400 239.7600 USD
Purchase 484 245.0859 USD
Purchase 574 245.2189 USD
Purchase 1,417 239.8616 USD
Purchase 4,623 241.5393 USD
Purchase 8,227 245.0420 USD
Purchase 10,359 242.7451 USD
Purchase 12,514 245.8624 USD
Purchase 17,802 242.7293 USD
Purchase 17,890 242.8421 USD
Purchase 23,738 245.8800 USD
Purchase 60,000 244.1800 USD
Purchase 69,892 243.4269 USD
Sale 1 243.7050 USD
Sale 2 244.4175 USD
Sale 2 243.5700 USD
Sale 3 245.0700 USD
Sale 3 245.3500 USD
Sale 3 244.1566 USD
Sale 4 243.7000 USD
Sale 5 243.4990 USD
Sale 6 244.3583 USD
Sale 6 244.5775 USD
Sale 6 245.0208 USD
Sale 6 243.7841 USD
Sale 7 244.2614 USD
Sale 7 246.3900 USD
Sale 8 246.0012 USD
Sale 14 246.0800 USD
Sale 14 246.2350 USD
Sale 17 244.7902 USD
Sale 21 243.0650 USD
Sale 21 245.1800 USD
Sale 35 244.2260 USD
Sale 35 245.8780 USD
Sale 51 241.1780 USD
Sale 71 242.9790 USD
Sale 78 245.9208 USD
Sale 100 244.7700 USD
Sale 100 245.8400 USD
Sale 178 246.1366 USD
Sale 200 235.2800 USD
Sale 238 245.8389 USD
Sale 256 244.8317 USD
Sale 291 238.8120 USD
Sale 400 242.2800 USD
Sale 700 245.9814 USD
Sale 800 245.3462 USD
Sale 885 245.7187 USD
Sale 1,021 244.9090 USD
Sale 1,026 244.4072 USD
Sale 2,177 242.5325 USD
Sale 2,297 243.1195 USD
Sale 2,626 245.1652 USD
Sale 3,002 239.9118 USD
Sale 3,120 241.6332 USD
Sale 4,438 244.7964 USD
Sale 4,447 243.3873 USD
Sale 12,519 245.8769 USD
Sale 12,947 242.7116 USD
Sale 13,741 243.7290 USD
Sale 15,693 242.7843 USD
Sale 17,839 242.8398 USD
Sale 22,033 245.8800 USD
Sale 44,762 243.2560 USD
Sale 50,000 244.1800 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 29 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210429005674/en/
(https://www.businesswire.com/news/home/20210429005674/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement